| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Harrison Seth Loring | Director | C/O AKERO THERAPEUTICS, INC., 601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO | /s/ Jonathan Young, Attorney-in-Fact | 2025-06-05 | 0001404955 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AKRO | Common Stock | Award | $0 | +9.4K | +6.9% | $0.00 | 146K | Jun 3, 2025 | Direct | F1 |
| holding | AKRO | Common Stock | 148K | Jun 3, 2025 | See Footnote | F2 |
| Id | Content |
|---|---|
| F1 | These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs shall vest in full on the earlier of (i) June 3, 2026, and (ii) the next annual meeting of the Company's stockholders, subject to the director's continued service on the Board. |
| F2 | Represents shares held directly by Les Pommes, LLC, a family limited liability company for which the Reporting Person is the manager. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |